.....but I don't know where the AWFUL news is.
This is part of Fresenius procedure.
Read again the news.
It's written "After 56k injections, we have enough data to analyze OMONTYS performance. At the moment we had 1:1000 adverse effects. Of these 1:1000, some were serious".
It's not written "We stops rolling out Omontys because of serious effects".
After that, it's written:
"we stop enrolling MORE patients and MORE delivering centers. With data on our hands, in 1/2 weeks we expect to communicate you our Medical Team's data analisys".
Well... if The medical Team decides to stop OMONTYS because dangerous, so it shall be.
Amen for our shares.
What I personally think is that it won't be so, because they RECOMMENDED to go on delivering to patients already under OMONTY..... because it did well (it's written, I'm not inventing).
And all - IMOpinion - will result in another line on a piece of paper into the box..
But the point is: in the 8-K form, there's no trace of bad news. It's their procedure.
Those who sell today are misreading. This is normal procedures and actually there are quite good news in the report as they recommend continued use on patients who already are on Omontys. Given some of what has been writen in that report, their final recommendations could actually be positive.